EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Tapentadol: A Comprehensive Review of Its Role in Pain Management

Esteban Zavaleta-Monestel, Adriana Anchía-Alfaro, Jorge Villalobos-Madriz, Amil Munich, Jonathan García-Montero, Ricardo Quesada-Villaseñor, Sebastián Arguedas-Chacón, Andrés Hernández-Ortiz, Roberto Rodríguez-Miranda

Cureus · 23.11.2024

DOI: 10.7759/cureus.74307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 23.11.2024. Verfasst von Esteban Zavaleta-Monestel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy, Hospital Clínica Bíblica, San José, CRI. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pain is a prevalent issue among patients, requiring effective management to prevent the transition of acute pain into chronic pain and to mitigate significant clinical and socioeconomic impacts, such as increased morbidity, mortality, prolonged recovery, unplanned readmissions, and diminished quality of life. Despite advancements in pain management guidelines, achieving consistent pain relief remains challenging due to individual differences in pain thresholds, the nature of surgical procedures, patient age, and existing comorbidities. Tapentadol, an opioid that acts as both a μ-opioid receptor agonist and a noradrenaline reuptake inhibitor, presents a promising option for pain management. Approved by the FDA in 2008 for immediate release and in 2011 for extended release, tapentadol effectively addresses both nociceptive and neuropathic pain, offering a more favorable efficacy-safety profile compared to traditional opioids such as tramadol. Additionally, tapentadol is gaining recognition as a preferred option for managing significant pain in cancer patients due to its effectiveness and reduced side effects. This review evaluates tapentadol's clinical and pharmacological attributes, systematically analyzing literature on its efficacy, safety, pharmacokinetics, and comparative effectiveness, suggesting that tapentadol is a viable option for effective pain management with potential for broader clinical applications.

Schlagwörter

Stichwörter der Autor:innen

analgesiacanceroncology painopioidspain managementtapentadol

Autor:innen und Institutionen

  • Pharmacy, Hospital Clínica Bíblica, San José, CRI.
  • Research, Hospital Clínica Bíblica, San José, CRI.
  • Pharmacy, Universidad Latina de Costa Rica, San José, CRI.
  • Pharmacology, Hospital Clínica Bíblica, San José, CRI.
  • Pain and Palliative Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MEX.
  • Anesthesiology, Hospital Clínica Bíblica, San José, CRI.

Zitieren

APA

Zavaleta-Monestel, E., Anchía-Alfaro, A., Villalobos-Madriz, J., Munich, A., García-Montero, J., Quesada-Villaseñor, R., Arguedas-Chacón, S., Hernández-Ortiz, A., & Rodríguez-Miranda, R. (2024). Tapentadol: A Comprehensive Review of Its Role in Pain Management. Cureus. https://doi.org/10.7759/cureus.74307

Vancouver

Zavaleta-Monestel E, Anchía-Alfaro A, Villalobos-Madriz J, Munich A, García-Montero J, Quesada-Villaseñor R, et al. Tapentadol: A Comprehensive Review of Its Role in Pain Management. Cureus. 2024. doi:10.7759/cureus.74307

BibTeX
@article{ZavaletaMonestel2024,
  author = {Zavaleta-Monestel, Esteban and Anchía-Alfaro, Adriana and Villalobos-Madriz, Jorge and Munich, Amil and García-Montero, Jonathan and Quesada-Villaseñor, Ricardo and Arguedas-Chacón, Sebastián and Hernández-Ortiz, Andrés and Rodríguez-Miranda, Roberto},
  title = {Tapentadol: A Comprehensive Review of Its Role in Pain Management},
  journal = {Cureus},
  year = {2024},
  doi = {10.7759/cureus.74307}
}
Kostenlos starten →